Your session is about to expire
← Back to Search
Behavioural Intervention
Respiratory Music Therapy for Post-Covid-19 Respiratory Symptoms
N/A
Waitlist Available
Led By Joanne V Loewy, DA
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a music therapy protocol to see if it can help people with post-Covid-19 respiratory symptoms. The goal is to improve quality of life by reducing fatigue, depression, and improving sleep and resilience.
Eligible Conditions
- COVID-19
- Shortness of Breath
- Post-Covid Respiratory Syndrome
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 12 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
MRC dyspnea score
Secondary study objectives
Beck Depression Inventory - short form (BDI-SF)
Connor-davidson Resilience Scale (CD-RISC)
Coronavirus Anxiety Scale (CAS)
+7 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Individuals living with post-Covid-19 respiratory symptomsExperimental Treatment1 Intervention
Live virtual music therapy interventions for people experiencing difficulties breathing after having had COVID-19 (diagnosed or presumed).
Find a Location
Who is running the clinical trial?
Icahn School of Medicine at Mount SinaiLead Sponsor
914 Previous Clinical Trials
570,846 Total Patients Enrolled
11 Trials studying COVID-19
23,570 Patients Enrolled for COVID-19
Joanne V Loewy, DAPrincipal InvestigatorDirector Louis Armstrong Center for Music & Medicine,
1 Previous Clinical Trials
82 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You are still having problems with your breathing and feeling tired.You have severe difficulty in breathing, as determined by a special breathing assessment.You have mild to moderate difficulty in breathing, as rated by a breathing test.You have respiratory problems, but you do not have a confirmed or likely diagnosis of COVID-19.
Research Study Groups:
This trial has the following groups:- Group 1: Individuals living with post-Covid-19 respiratory symptoms
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.